Start of co-development of skincare devices and consumables

Source: 바카라 사이트
Source: Shaperon

[by Yu, Suin] Shaperon announced on August 27 that it has entered into a memorandum of understanding (MOU) with the K-beauty device company Attibe Beauty to co-develop skincare devices and consumables incorporating High-Intensity Focused Ultrasound (HIFU) technology. The partnership aims to facilitate entry into the global market.

바카라 사이트 is a technology that delivers high-intensity focused ultrasound energy at precise depths in the skin to selectively break down tissue and stimulate regenerative processes. It is widely used for a range of dermatological and aesthetic indications, including jawline contouring, skin lifting, and wrinkle reduction. In comparison with conventional incisional procedures or radiofrequency-based treatments, 바카라 사이트 allows faster recovery with fewer adverse effects, factors that have contributed to its widespread adoption in beauty clinics, dermatology practices, and plastic surgery centers. The global 바카라 사이트 market is also experiencing rapid growth.

The medical community has long applied non-surgical methods to treat deep-seated malignancies. Among these, 바카라 사이트 is increasingly valued for its capacity to precisely concentrate ultrasound energy on cancerous tissues, destroying cancer cells and stimulating immune cells to strengthen the patient's overall immune function.

Shaperon recently reported the results of an animal study demonstrating that the combination of 바카라 사이트 technology with dendritic cell-based anticancer immunotherapy achieved a 93.9% inhibition of cancer metastasis. This approach is regarded as a groundbreaking method for reducing cancer recurrence while boosting immune function. The company further emphasized that this collaboration represents an important step in translating such medical advances into the aesthetics and healthcare sectors.

Under its ‘Homethera’ brand, Attibe Beauty has developed a portable, domestically produced 바카라 사이트 homecare device. Incorporating multiple cartridge technologies, the device allows for precise and customizable application and has obtained domestic and international certifications. The company has established a leading market position with its technology to effectively address curved anatomical areas, such as the periorbital and perioral areas.

Under the agreement, the two companies plan to further upgrade device performance to maximize lifting effects and skin elasticity in accordance with dermatological principles, while also developing a 바카라 사이트-specific gel optimized for the management of inflammation and edema. Shaperon's inflammasome inhibitor candidate, ‘NuGel,’ has already demonstrated safety and efficacy in domestic and international clinical trials. A second-generation compound synthesized from NuGel will be incorporated into the gel formulation currently under development, which is expected to attenuate excessive inflammation and swelling, accelerate recovery, and augment skin improvements.

"The integration of our anti-inflammatory gel formulation and Attibe 바카라 사이트's high-performance device represents an innovative approach that will accelerate the development of the global 바카라 사이트, medical, and healthcare sectors, while advancing the convergence of K-bio and 바카라 사이트. This collaboration will not only enhance the safety and efficacy of procedures but also open the door for Korean companies to set a new standard in the global aesthetic medical device market," a Shaperon official stated.

The global aesthetic medical device market, valued at approximately USD 121.7 billion (KRW 169.4429 trillion) in 2024, is projected to expand to USD 355.2 billion by 2032. This trajectory reflects an anticipated compound annual growth rate of approximately 12-14%.

저작권자 © 더바이오 무단전재 및 재배포 금지